Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Anna, Eisert"'
Autor:
Oliver Illini, Felix Carl Saalfeld, Petros Christopoulos, Michaël Duruisseaux, Anders Vikström, Nir Peled, Ingel Demedts, Elizabeth Dudnik, Anna Eisert, Sayed M. S. Hashemi, Urska Janzic, Waleed Kian, Katja Mohorcic, Saara Mohammed, Maria Silvoniemi, Sacha I. Rothschild, Christian Schulz, Claas Wesseler, Alfredo Addeo, Karin Armster, Malinda Itchins, Marija Ivanović, Diego Kauffmann-Guerrero, Jussi Koivunen, Jonas Kuon, Nick Pavlakis, Berber Piet, Martin Sebastian, Janna-Lisa Velthaus-Rusik, Luciano Wannesson, Marcel Wiesweg, Robert Wurm, Corinna Albers-Leischner, Daniela E. Aust, Melanie Janning, Hannah Fabikan, Sylvia Herold, Anna Klimova, Sonja Loges, Yana Sharapova, Maret Schütz, Christoph Weinlinger, Arschang Valipour, Tobias Raphael Overbeck, Frank Griesinger, Marko Jakopovic, Maximilian J. Hochmair, Martin Wermke
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 7, p 3992 (2024)
EGFR exon 20 (EGFR Ex20) insertion mutations in non-small cell lung cancer (NSCLC) are insensitive to traditional EGFR tyrosine kinase inhibitors (TKIs). Mobocertinib is the only approved TKI specifically designed to target EGFR Ex20. We performed an
Externí odkaz:
https://doaj.org/article/6ed7bccf8a6a4049820a8177574fd8c6
Autor:
Mihaela Aldea, Arianna Marinello, Michael Duruisseaux, Wael Zrafi, Nicole Conci, Giacomo Massa, Giulio Metro, Isabelle Monnet, Patricia Gomez Iranzo, Fabrizio Tabbo, Emilio Bria, Florian Guisier, Damien Vasseur, Colin R. Lindsay, Santiago Ponce-Aix, Sophie Cousin, Fabrizio Citarella, Vincent Fallet, Jose Nicolas Minatta, Anna Eisert, Hortense de Saint Basile, Clarisse Audigier-Valette, Laura Mezquita, Antonio Calles, Giannis Mountzios, Marco Tagliamento, Jordi Remon Masip, Judith Raimbourg, Safae Terrisse, Alessandro Russo, Diego Cortinovis, Philippe Rochigneux, David James Pinato, Alessio Cortellini, Camille Leonce, Anas Gazzah, Maria-Rosa Ghigna, Roberto Ferrara, Filippo Gustavo Dall’Olio, Francesco Passiglia, Vienna Ludovini, Fabrice Barlesi, Enriqueta Felip, David Planchard, Benjamin Besse
Publikováno v:
Scientia
Chemotherapy; Non–small cell lung cancer; RET inhibitors Quimioteràpia; Càncer de pulmó de cèl·lules no petites; Inhibidors de RET Quimioterapia; Cáncer de pulmón de células no pequeñas; Inhibidores de RET Introduction Nearly 1% to 2% of N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57f7bd4756ed222514ab170ab21d1c3d
https://doi.org/10.1016/j.jtho.2022.12.018
https://doi.org/10.1016/j.jtho.2022.12.018
Autor:
Theresa Reutter, Jana Fassunke, Michael Püsken, Jan-Phillip Weber, Elke Binot, Anna Eisert, Rieke Fischer, Lucia Nogova, Richard Riedel, Diana Schaufler, Heather Scharpenseel, Matthias Scheffler, Holger Schulz, Dirk‐Thomas Waldschmidt, Thomas Zander, Sabine Merkelbach-Bruse, Peter Schirmacher, Reinhard Büttner, Jürgen Wolf, Sebastian Michels
Publikováno v:
JCO Precision Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::537dcdc497bef9629af8b90cb9d696fc
https://doi.org/10.1200/po.22.00467
https://doi.org/10.1200/po.22.00467
Autor:
Jürgen Wolf, Reinhard Büttner, Mathieu Clement-Ziza, Lukas C. Heukamp, Britta Kaminsky, Thomas Geist, Ulrich Gerigk, Yon-Dschun Ko, Monika Serke, Carina Heydt, Jana Fassunke, Anna Eisert, Rieke Fischer, Sebastian Michels, Katharina König, Frank Ueckeroth, Michael Rauer, Anna Kron, Michaela A. Ihle, Sabine Merkelbach-Bruse, Matthias Scheffler, Rieke Frank
Purpose: KEAP1 and NFE2L2 mutations are associated with impaired prognosis in a variety of cancers and with squamous cell carcinoma formation in non–small cell lung cancer (NSCLC). However, little is known about frequency, histology dependence, mol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::438570b1ec0685eb9b4c9f90d1ab3452
https://doi.org/10.1158/1078-0432.c.6527654.v1
https://doi.org/10.1158/1078-0432.c.6527654.v1
Autor:
Jürgen Wolf, Reinhard Büttner, Mathieu Clement-Ziza, Lukas C. Heukamp, Britta Kaminsky, Thomas Geist, Ulrich Gerigk, Yon-Dschun Ko, Monika Serke, Carina Heydt, Jana Fassunke, Anna Eisert, Rieke Fischer, Sebastian Michels, Katharina König, Frank Ueckeroth, Michael Rauer, Anna Kron, Michaela A. Ihle, Sabine Merkelbach-Bruse, Matthias Scheffler, Rieke Frank
Supplemental Table 1-7 Supplemental Table 1: Diagnostic panels used for Next-generation sequencing (NGS) Supplemental Table 2: KEAP1 mutations Supplemental Table 3: NFE2L2 mutations Supplemental Table 4: Co-aberrations of KEAP1 Supplemental Table 5:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26f036f5e01c6e1155e337dc9abeb9da
https://doi.org/10.1158/1078-0432.22470680
https://doi.org/10.1158/1078-0432.22470680
Autor:
Jürgen Wolf, Reinhard Büttner, Mathieu Clement-Ziza, Lukas C. Heukamp, Britta Kaminsky, Thomas Geist, Ulrich Gerigk, Yon-Dschun Ko, Monika Serke, Carina Heydt, Jana Fassunke, Anna Eisert, Rieke Fischer, Sebastian Michels, Katharina König, Frank Ueckeroth, Michael Rauer, Anna Kron, Michaela A. Ihle, Sabine Merkelbach-Bruse, Matthias Scheffler, Rieke Frank
Main characteristics of the control group.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90f2126ee0c9e620a395f2041814bcda
https://doi.org/10.1158/1078-0432.22470677.v1
https://doi.org/10.1158/1078-0432.22470677.v1
Autor:
Richard Riedel, Jana Fassunke, Hannah L. Tumbrink, Andreas H. Scheel, Carina Heydt, Lena Hieggelke, Matthias Scheffler, Alena Heimsoeth, Lucia Nogova, Sebastian Michels, Jan-Phillip Weber, Rieke N. Fischer, Anna Eisert, Theresa Westphal, Diana Schaufler, Janna Siemanowski, Michaela A. Ihle, Svenja Wagener-Ryczek, Roberta Castiglione, Roberto Pappesch, Jan Rehker, Jessica Jürgens, Erich Stoelben, Anne Bunck, Carsten Kobe, Sabine Merkelbach-Bruse, Martin L. Sos, Reinhard Büttner, Jürgen Wolf
Publikováno v:
European journal of cancer (Oxford, England : 1990). 179
Resistance to MET inhibition occurs inevitably in MET-dependent non-small cell lung cancer and the underlying mechanisms are insufficiently understood. We describe resistance mechanisms in patients with MET exon 14 skipping mutation (METΔPre- and po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fb73d72da1bbefa79f46955569df0e6
https://pubmed.ncbi.nlm.nih.gov/36521334
https://pubmed.ncbi.nlm.nih.gov/36521334
Autor:
Heather Scharpenseel, Florian Malchers, Inken Terjung, Axel Hillmer, Sabine Merkelbach-Bruse, Andreas H. Scheel, Janna Siemanowski, Matthias Scheffler, Richard Riedel, Anna Eisert, Sebastian Yves Friedrich Michels, Rieke Nila Fischer, Jan-Philip Weber, Theresa Westphal, Anna Kron, Juliane Sueptitz, Roman K. Thomas, Reinhard Buettner, Juergen Wolf, Lucia Nogova
Publikováno v:
Journal of Clinical Oncology. 40:e21013-e21013
e21013 Background: The fibroblast growth factor receptor (FGFR) 1-4 genes show a heterogenic landscape of alterations in non-small cell lung cancer (NSCLC) whereas only a small amount is yet considered to have oncogenic potential. The frequency of ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d81d1dc9ddc5af139d1e1c755ab87290
https://doi.org/10.1200/jco.2022.40.16_suppl.e21013
https://doi.org/10.1200/jco.2022.40.16_suppl.e21013
Autor:
Moritz Glaser, Cornelia von Levetzow, Sebastian Yves Friedrich Michels, Lucia Nogova, Marianna Katzenmeier, Claudia Wompner, Jaqueline Schmitz, Elisabeth Bitter, Inken Terjung, Elke Passmann, Diana Schaufler, Anna Eisert, Rieke Nila Fischer, Richard Riedel, Jan-Phillip Weber, Sabine Hahne, Sabine Merkelbach-Bruse, Reinhard Büttner, Juergen Wolf, Matthias Scheffler
Publikováno v:
Journal of Clinical Oncology. 40:e21117-e21117
e21117 Background: Fusions in the ROS1 proto-oncogene are among the best treatable genetic aberrations in Non-small cell lung cancer (NSCLC). Besides the occurrence of solvent-front mutations (SFM) in acquired resistance to targeted therapy, little i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b679b1981f30091887866e02df135caa
https://doi.org/10.1200/jco.2022.40.16_suppl.e21117
https://doi.org/10.1200/jco.2022.40.16_suppl.e21117
Autor:
Britta Kaminsky, Reinhard Büttner, Frank Ueckeroth, Anna Eisert, Jana Fassunke, Ulrich Gerigk, Carina Heydt, Yon-Dschun Ko, Mathieu Clément-Ziza, Lukas C. Heukamp, Thomas Geist, Jürgen Wolf, Matthias Scheffler, Katharina König, Anna Kron, Sabine Merkelbach-Bruse, Sebastian Michels, Monika Serke, Michaela Angelika Ihle, Rieke Frank, Michael Rauer, Rieke Fischer
Publikováno v:
Clinical Cancer Research. 24:3087-3096
Purpose: KEAP1 and NFE2L2 mutations are associated with impaired prognosis in a variety of cancers and with squamous cell carcinoma formation in non–small cell lung cancer (NSCLC). However, little is known about frequency, histology dependence, mol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0be8a3e9db755535fe7f94c4f93fa9e6
https://doi.org/10.1158/1078-0432.ccr-17-3416
https://doi.org/10.1158/1078-0432.ccr-17-3416